High free fatty acids level related with cardiac dysfunction in obese rats

Marinou, 2010, Obesity and cardiovascular disease: from pathophysiology to risk stratification, Int J Cardiol, 138, 3, 10.1016/j.ijcard.2009.03.135 Morse, 2010, The obesity paradox and cardiovascular disease, Curr Hypertens Rep, 12, 120, 10.1007/s11906-010-0099-1 Loehr, 2010, The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study, Am J Epidemiol, 10.1093/aje/kwq213 Nicklas, 2006, Abdominal obesity is an independent risk factor for chronic heart failure in older people, J Am Geriatr Soc, 54, 413, 10.1111/j.1532-5415.2005.00624.x Lakhani, 2011, Effects of obesity and subsequent weight reduction on left ventricular function, Cardiol Rev, 19, 1, 10.1097/CRD.0b013e3181f877d2 Coviello, 2003, Obesity and heart failure, J Cardiovasc Nurs, 18, 360, 10.1097/00005082-200311000-00007 Chirinos, 2010, Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance, Hypertension, 56, 91, 10.1161/HYPERTENSIONAHA.110.150250 Rider, 2009, Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study, J Cardiovasc Magn Reson, 11, 9, 10.1186/1532-429X-11-9 Kardassis, 2011, Impact of body composition, fat distribution and sustained weight loss on cardiac function in obesity, Int J Cardiol, 10.1016/j.ijcard.2011.02.036 Frohlich, 2008, Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension, Curr Hypertens Rep, 10, 151, 10.1007/s11906-008-0028-8 Buchanan, 2005, Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity, Endocrinology, 146, 5341, 10.1210/en.2005-0938 Aasum, 2008, Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice, J Mol Cell Cardiol, 44, 201, 10.1016/j.yjmcc.2007.08.020 Mazumder, 2004, Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts, Diabetes, 53, 2366, 10.2337/diabetes.53.9.2366 Schaffer, 2003, When tissues overeat, Curr Opin Lipidol, 14, 281, 10.1097/00041433-200306000-00008 Ke, 2009, The effect and pathophysiological mechanism of high free fatty acids (FfAs) on the cardiac structure and function, Sichuan Da Xue Xue Bao Yi Xue Ban, 40, 24 Zhou, 2000, Lipotoxic heart disease in obese rats: implications for human obesity, Proc Natl Acad Sci USA, 97, 1784, 10.1073/pnas.97.4.1784 Peterson, 2008, Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes, Diabetes, 57, 32, 10.2337/db07-1199 Young, 2002, Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart, Diabetes, 51, 2587, 10.2337/diabetes.51.8.2587 Lin, 1995, Peroxynitrite-induced apoptosis in HL-60 cells, J Biol Chem, 270, 16487, 10.1074/jbc.270.28.16487 Pu, 2010, Effect of inflammation factors on endothelial function in insulin resistance SD rats, Sichuan Da Xue Xue Bao Yi Xue Ban, 41 Sun, 2011, Effect of aspirin on the expression of hepatocyte NF-kappaB and Serum TNF-alpha in streptozotocin-induced type 2 diabetic rats, J Korean Med Sci, 26, 765, 10.3346/jkms.2011.26.6.765 Feuerstein, 1998, Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol, Prog Cardiovasc Dis, 41, 17, 10.1016/S0033-0620(98)80027-3 Purcell, 2001, Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes, Proc Natl Acad Sci USA, 98, 6668, 10.1073/pnas.111155798 Ha, 2005, Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo, Free Radic Biol Med, 39, 1570, 10.1016/j.freeradbiomed.2005.08.002 Kan, 1999, TNF-alpha enhances cardiac myocyte NO production through MAP kinase-mediated NF-kappaB activation, Am J Physiol, 277, H1641 Piro, 2002, Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress, Metabolism, 51, 1340, 10.1053/meta.2002.35200 Bhatia, 2005, Angiotensin receptor blockers in congestive heart failure: evidence, concerns, and controversies, Cardiol Rev, 13, 297, 10.1097/01.crd.0000148236.34855.18 Verdecchia, 2009, Blood pressure reduction and renin–angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis, Eur Heart J, 30, 679, 10.1093/eurheartj/ehn575 Guo, 2005, Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin–angiotensin system, Expert Rev Cardiovasc Ther, 3, 717, 10.1586/14779072.3.4.717 Ainscough, 2009, Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction, Cardiovasc Res, 81, 592, 10.1093/cvr/cvn230 Dostal, 2000, The cardiac renin–angiotensin system: novel signaling mechanisms related to cardiac growth and function, Regul Pept, 91, 1, 10.1016/S0167-0115(99)00123-8 Serneri, 2001, Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function, Circ Res, 88, 961, 10.1161/hh0901.089882